Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-06-11
2008-03-25
Rao, Manjunath (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C435S069100, C530S327000, C530S326000
Reexamination Certificate
active
07348155
ABSTRACT:
The invention relates to a method for identifying a compound which modifies the activity of the urotensin II receptor, with genes or gene products which are involved in the structure, formation or breakdown of the extracellular matrix being influenced.
REFERENCES:
patent: WO99/40192 (1999-08-01), None
patent: WO00/75168 (2000-12-01), None
patent: WO 01/14888 (2001-03-01), None
Cotran, et al. Editors. Robbins Pathologic Basis of Disease, 6th edition, 1999, pp. 544.
Alberts, et al. 2002. Molecular Biology of the Cell. 4th edition, pp. 1090-1091.
Douglas SA and Ohlstein EH. 2000. Trends Cardiovasc Med. 10:229-237.
Liu et al., 1999. World J Gastroenterology 6:361-364.
Tzanidis et al. 2000. European Heart J. 21 Supp [S]:72 (p. 516).
Deten et al. 2001. J Mol Cell Cardiol 33:1191-1207.
Ghosh 2002. Exp Biol Med 227:301-314.
M. Neuss et al., Isolation and Characterization of Human Cardiac Fibroblasts From Explanted Adult Hearts, Cell & Tissue Research, vol. 286, 1996, pp. 145-153.
A. Tzanidis et al., Urotensin II Stimulates Collagen Synthesis By Cardiac Fibroblasts And Hypertrophic Signalling In Cardiomyocytes Via G(alpha)q- and Ras-dependent Pathways, Journ. of American College of Cardiology, vol. 37, No. 2, Feb. 2001, p. 164A.
Fitzgerald et al., Matrix metalloproteinases can facilitate the heparanase-induced promotion of phenotypic chane in vascular smooth muscle cells, Atherosclerosis, vol. 145, No. 1, Jul. 1999, pp. 97-106.
Chen et al., CTGF Expression is Induced by TGF-Beta in Cardiac Fibroblasts and Cardiac Myocytes: a Potential Role in Heart Fibrosis, Journ. of Molecular and Celluclar Cardiology, vol. 32, No. 10, Oct. 2000, pp. 1805-1819.
Douglas et al., Human Urotension-II, the Most Potent Mammalian Vasconstrictor Identified To Date, as a Therapeutic Target for the Management of Cardiovascular Disease, Trends in Cardiovascular Medicine, vol. 10, No. 6, Aug. 2000, pp. 229-237.
Busch Andreas
Kostenis Evi
Regitz-Zagrosek Vera
Rao Manjunath
Sanofi-Aventis Deutschland GmbH
Shafer Shulamith H
LandOfFree
Method for identifying compounds for treating aging... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying compounds for treating aging..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying compounds for treating aging... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3974374